| scholarly article | Q13442814 |
| P356 | DOI | 10.1074/JBC.M101890200 |
| P698 | PubMed publication ID | 11313352 |
| P2093 | author name string | Knight JS | |
| Robertson ES | |||
| Cotter MA 2nd | |||
| P2860 | cites work | hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization | Q24310670 |
| Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT | Q24313396 | ||
| Identification of the gene encoding the major latency-associated nuclear antigen of the Kaposi's sarcoma-associated herpesvirus | Q24561400 | ||
| Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8) | Q24650427 | ||
| Specific Association of Human Telomerase Activity with Immortal Cells and Cancer | Q27860801 | ||
| Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma | Q28242984 | ||
| Telomerase activation by hTRT in human normal fibroblasts and hepatocellular carcinomas | Q28258624 | ||
| The RNA component of human telomerase | Q28288330 | ||
| Telomere length regulation | Q28290143 | ||
| Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma in patients with and without HIV infection | Q28299060 | ||
| Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas | Q28299069 | ||
| TLP1: a gene encoding a protein component of mammalian telomerase is a novel member of WD repeats family | Q28564535 | ||
| A mammalian telomerase-associated protein | Q28595030 | ||
| A survey of telomerase activity in human cancer | Q29614858 | ||
| A highly conserved repetitive DNA sequence, (TTAGGG)n, present at the telomeres of human chromosomes | Q29617061 | ||
| Efficient persistence of extrachromosomal KSHV DNA mediated by latency-associated nuclear antigen | Q33859518 | ||
| Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) binds ATF4/CREB2 and inhibits its transcriptional activation activity | Q33922095 | ||
| Seroconversion to antibodies against Kaposi's sarcoma-associated herpesvirus-related latent nuclear antigens before the development of Kaposi's sarcoma | Q34383343 | ||
| Telomerase activity in the regenerative basal layer of the epidermis inhuman skin and in immortal and carcinoma-derived skin keratinocytes | Q34387542 | ||
| The latent nuclear antigen of Kaposi sarcoma-associated herpesvirus targets the retinoblastoma-E2F pathway and with the oncogene Hras transforms primary rat cells | Q34511161 | ||
| Production by EBV infection of an EBNA-positive subline from an EBNA-negative human lymphoma cell line without detectable EBV DNA | Q34571530 | ||
| Temporal trends of opportunistic infections and malignancies in homosexual men with AIDS. | Q34725759 | ||
| Kaposi's sarcoma among persons with AIDS: a sexually transmitted infection? | Q34996973 | ||
| Translocation of the c-myc gene into the immunoglobulin heavy chain locus in human Burkitt lymphoma and murine plasmacytoma cells | Q36327408 | ||
| Chromosome first aid. | Q37430022 | ||
| Sp1 cooperates with c-Myc to activate transcription of the human telomerase reverse transcriptase gene (hTERT). | Q38316509 | ||
| Identification and characterization of negative regulatory elements of the human telomerase catalytic subunit (hTERT) gene promoter: possible role of MZF-2 in transcriptional repression of hTERT. | Q39543159 | ||
| Kaposi's sarcoma. Epidemiology, pathogenesis, histology, clinical spectrum, staging criteria and therapy | Q40882026 | ||
| Molecular polymorphism of Kaposi's sarcoma-associated herpesvirus (Human herpesvirus 8) latent nuclear antigen: evidence for a large repertoire of viral genotypes and dual infection with different viral genotypes. | Q40923894 | ||
| Distinct patterns of viral antigen expression in Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus coinfected body-cavity-based lymphoma cell lines: potential switches in latent gene expression due to coinfection | Q40928603 | ||
| Direct activation of TERT transcription by c-MYC. | Q40973563 | ||
| Decrease in amplified telomeric sequences and induction of senescence markers by introduction of human chromosome 7 or its segments in SUSM-1. | Q41090781 | ||
| Replicative senescence and cell immortality: the role of telomeres and telomerase | Q41130848 | ||
| Propagation of a human herpesvirus from AIDS-associated Kaposi's sarcoma | Q41134075 | ||
| Telomerase and cancer: revisiting the telomere hypothesis | Q41211805 | ||
| Telomerase activation by the E6 gene product of human papillomavirus type 16. | Q41218028 | ||
| Functional characterization and developmental regulation of mouse telomerase RNA. | Q41306667 | ||
| Adenovirus 5 DNA sequences present and RNA sequences transcribed in transformed human embryo kidney cells (HEK-Ad-5 or 293) | Q41657050 | ||
| Kaposi's sarcoma. Retrospective study of 90 cases with particular emphasis on the familial occurrence, ethnic background and prevalence of other diseases | Q44114816 | ||
| Herpes-Like DNA Sequences in a Body-Cavity–Based Lymphoma in an HIV-Negative Patient | Q44541217 | ||
| Transformation of primary human endothelial cells by Kaposi's sarcoma-associated herpesvirus | Q47675996 | ||
| Telomerase reverse transcriptase gene is a direct target of c-Myc but is not functionally equivalent in cellular transformation | Q47987665 | ||
| Neoplastic transformation of human diploid fibroblasts (KMST-6) by treatment with 60Co gamma rays. | Q52832421 | ||
| Sugar and Disease | Q59060231 | ||
| Kaposi's sarcoma-associated herpesvirus infects endothelial and spindle cells | Q71563744 | ||
| The latency-associated nuclear antigen tethers the Kaposi's sarcoma-associated herpesvirus genome to host chromosomes in body cavity-based lymphoma cells | Q73184792 | ||
| The Wilms' tumor 1 tumor suppressor gene represses transcription of the human telomerase reverse transcriptase gene | Q73280057 | ||
| Expression of human telomerase subunits in ovarian malignant, borderline and benign tumors | Q74601071 | ||
| hTERT is a critical determinant of telomerase activity in renal-cell carcinoma | Q77531661 | ||
| P433 | issue | 25 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 22971-22978 | |
| P577 | publication date | 2001-04-19 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus transactivates the telomerase reverse transcriptase promoter | |
| P478 | volume | 276 |
| Q38073761 | AKTivation of PI3K/AKT/mTOR signaling pathway by KSHV. |
| Q34648229 | Acetylation of the latency-associated nuclear antigen regulates repression of Kaposi's sarcoma-associated herpesvirus lytic transcription. |
| Q39675686 | Bub1 and CENP-F can contribute to Kaposi's sarcoma-associated herpesvirus genome persistence by targeting LANA to kinetochores |
| Q35943718 | Carboxyl-terminal amino acids 1052 to 1082 of the latency-associated nuclear antigen (LANA) interact with RBP-Jκ and are responsible for LANA-mediated RTA repression. |
| Q39365643 | Cdk1 inhibition induces mutually inhibitory apoptosis and reactivation of Kaposi's sarcoma-associated herpesvirus |
| Q26749612 | Cell Cycle Regulatory Functions of the KSHV Oncoprotein LANA |
| Q40169138 | Deregulation of c-Myc in primary effusion lymphoma by Kaposi's sarcoma herpesvirus latency-associated nuclear antigen |
| Q40163096 | Disruption of Kaposi's sarcoma-associated herpesvirus latent nuclear antigen leads to abortive episome persistence |
| Q41891421 | Disruption of LANA in rhesus rhadinovirus generates a highly lytic recombinant virus |
| Q39744147 | Distinct p53, p53:LANA, and LANA complexes in Kaposi's Sarcoma--associated Herpesvirus Lymphomas |
| Q92664567 | Diverse regulatory manners of human telomerase reverse transcriptase |
| Q39629572 | Epstein-Barr Virus nuclear antigen 1 (EBNA1) confers resistance to apoptosis in EBV-positive B-lymphoma cells through up-regulation of survivin |
| Q36099024 | Epstein-Barr virus latent nuclear antigens can induce metastasis in a nude mouse model |
| Q24311421 | Epstein-Barr virus nuclear antigen 3C interacts with and enhances the stability of the c-Myc oncoprotein |
| Q34302223 | Epstein-Barr virus protein can upregulate cyclo-oxygenase-2 expression through association with the suppressor of metastasis Nm23-H1 |
| Q40288802 | Expression of alpha V integrin is modulated by Epstein-Barr virus nuclear antigen 3C and the metastasis suppressor Nm23-H1 through interaction with the GATA-1 and Sp1 transcription factors |
| Q34348453 | Functional dissection of latency-associated nuclear antigen 1 of Kaposi's sarcoma-associated herpesvirus involved in latent DNA replication and transcription of terminal repeats of the viral genome. |
| Q30479353 | HHV-8 encoded LANA-1 alters the higher organization of the cell nucleus |
| Q37867038 | Horizontal gene transfers with or without cell fusions in all categories of the living matter |
| Q40730661 | Human papillomavirus E2 down-regulates the human telomerase reverse transcriptase promoter |
| Q37905799 | Human telomerase expression regulation |
| Q24646461 | Identification of a novel cellular transcriptional repressor interacting with the latent nuclear antigen of Kaposi's sarcoma-associated herpesvirus |
| Q41839438 | In vivo-restricted and reversible malignancy induced by human herpesvirus-8 KSHV: a cell and animal model of virally induced Kaposi's sarcoma. |
| Q47840799 | Inactivation of hTERT transcription by Tax. |
| Q33843211 | Induction of Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen by the lytic transactivator RTA: a novel mechanism for establishment of latency |
| Q39794624 | Inhibition of KSHV-infected primary effusion lymphomas in NOD/SCID mice by gamma-secretase inhibitor. |
| Q40267803 | Intracellular activated Notch1 is critical for proliferation of Kaposi's sarcoma-associated herpesvirus-associated B-lymphoma cell lines in vitro |
| Q28540116 | Kaposi sarcoma herpes virus latency associated nuclear antigen protein release the G2/M cell cycle blocks by modulating ATM/ATR mediated checkpoint pathway |
| Q44277985 | Kaposi's sarcoma associated herpesvirus G protein-coupled receptor immortalizes human endothelial cells by activation of the VEGF receptor-2/ KDR. |
| Q36019173 | Kaposi's sarcoma herpesvirus-encoded latency-associated nuclear antigen stabilizes intracellular activated Notch by targeting the Sel10 protein |
| Q35665756 | Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen induction by hypoxia and hypoxia-inducible factors |
| Q42049779 | Kaposi's sarcoma-associated herpesvirus latent protein LANA interacts with HIF-1 alpha to upregulate RTA expression during hypoxia: Latency control under low oxygen conditions |
| Q33737793 | Kaposi's sarcoma-associated herpesvirus reactivation is regulated by interaction of latency-associated nuclear antigen with recombination signal sequence-binding protein Jkappa, the major downstream effector of the Notch signaling pathway |
| Q40607781 | Kaposi's sarcoma-associated herpesvirus-encoded LANA can induce chromosomal instability through targeted degradation of the mitotic checkpoint kinase Bub1 |
| Q34841987 | Kaposi's sarcoma-associated herpesvirus-encoded LANA down-regulates IL-22R1 expression through a cis-acting element within the promoter region |
| Q34128791 | Latency-associated nuclear antigen (LANA) cooperatively binds to two sites within the terminal repeat, and both sites contribute to the ability of LANA to suppress transcription and to facilitate DNA replication |
| Q40317413 | Latency-associated nuclear antigen (LANA) of Kaposi's sarcoma-associated herpesvirus interacts with origin recognition complexes at the LANA binding sequence within the terminal repeats |
| Q40682995 | Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus functionally interacts with heterochromatin protein 1. |
| Q24670086 | Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus recruits uracil DNA glycosylase 2 at the terminal repeats and is important for latent persistence of the virus |
| Q39992257 | Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus up-regulates transcription of human telomerase reverse transcriptase promoter through interaction with transcription factor Sp1. |
| Q34437977 | Mitotic chromosome-binding activity of latency-associated nuclear antigen 1 is required for DNA replication from terminal repeat sequence of Kaposi's sarcoma-associated herpesvirus |
| Q26860203 | Modeling human endothelial cell transformation in vascular neoplasias |
| Q35138059 | Molecular biology and pathogenesis of Kaposi sarcoma-associated herpesvirus |
| Q35026060 | Molecular genetics of Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) epidemiology and pathogenesis |
| Q37355889 | Nuclear translocated Ehrlichia chaffeensis ankyrin protein interacts with a specific adenine-rich motif of host promoter and intronic Alu elements |
| Q40173321 | ORF73 of Herpesvirus Saimiri Strain C488 Tethers the Viral Genome to Metaphase Chromosomes and Binds to cis -Acting DNA Sequences in the Terminal Repeats |
| Q37511491 | ORF73 of herpesvirus saimiri, a viral homolog of Kaposi's sarcoma-associated herpesvirus, modulates the two cellular tumor suppressor proteins p53 and pRb. |
| Q28257238 | On the road to immortality: hTERT upregulation in cancer cells |
| Q35174136 | Pathogenesis of Kaposi's sarcoma |
| Q33282107 | Protein complexes associated with the Kaposi's sarcoma-associated herpesvirus-encoded LANA. |
| Q24538878 | Protein interactions targeting the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus to cell chromosomes |
| Q34292265 | Regulation and autoregulation of the promoter for the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus |
| Q40398026 | Regulation of matrix metalloproteinase 9 expression by Epstein-Barr virus nuclear antigen 3C and the suppressor of metastasis Nm23-H1. |
| Q34535621 | Regulation of the human telomerase reverse transcriptase gene |
| Q38144129 | Review of latent and lytic phase biomarkers in Kaposi's sarcoma |
| Q35192690 | Ribosomal protein S6 interacts with the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus |
| Q99616354 | Role of DNA methylation and CpG sites in the viral telomerase RNA promoter during Gallid herpesvirus 2 pathogenesis |
| Q37157253 | Role of Kaposi's sarcoma-associated herpesvirus C-terminal LANA chromosome binding in episome persistence |
| Q38267908 | Sp1 and the 'hallmarks of cancer'. |
| Q35124429 | Structure and function of latency-associated nuclear antigen |
| Q36868580 | Telomerase as a useful target in cancer fighting-the breast cancer case |
| Q37765230 | Telomere/telomerase interplay in virus-driven and virus-independent lymphomagenesis: pathogenic and clinical implications |
| Q35857290 | The ATM/ATR signaling effector Chk2 is targeted by Epstein-Barr virus nuclear antigen 3C to release the G2/M cell cycle block |
| Q36301221 | The Kaposi Sarcoma Herpesvirus Latency-associated Nuclear Antigen DNA Binding Domain Dorsal Positive Electrostatic Patch Facilitates DNA Replication and Episome Persistence. |
| Q26767186 | The Role of Gammaherpesviruses in Cancer Pathogenesis |
| Q36080884 | The Telomerase Inhibitor MST-312 Interferes with Multiple Steps in the Herpes Simplex Virus Life Cycle |
| Q34178308 | The Viral Latency-Associated Nuclear Antigen Augments the B-Cell Response to AntigenIn Vivo |
| Q34391203 | The latency-associated nuclear antigen of Kaposi sarcoma-associated herpesvirus induces B cell hyperplasia and lymphoma |
| Q35104781 | The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus manipulates the activity of glycogen synthase kinase-3beta |
| Q40496132 | The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus modulates cellular gene expression and protects lymphoid cells from p16 INK4A-induced cell cycle arrest |
| Q33834414 | The latency-associated nuclear antigen of rhesus monkey rhadinovirus inhibits viral replication through repression of Orf50/Rta transcriptional activation |
| Q35077558 | The single RBP-Jkappa site within the LANA promoter is crucial for establishing Kaposi's sarcoma-associated herpesvirus latency during primary infection |
| Q26739925 | Transcription Regulation of the Human Telomerase Reverse Transcriptase (hTERT) Gene |
| Q39960021 | Transcriptional activation by the Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen is facilitated by an N-terminal chromatin-binding motif. |
Search more.